Search for: "Boehringer Ingelheim Pharmaceuticals"
Results 1 - 20
of 252
Sort by Relevance
|
Sort by Date
9 May 2024, 10:55 am
Other pharmaceutical giants, including GSK, Sanofi, and Boehringer Ingelheim, also face numerous lawsuits related to Zantac. [read post]
6 May 2024, 8:26 am
” Warning letters were sent to 10 manufacturers, including, among others, Teva (identifying 58 listings), Novo Nordisk (36 listings), and Boehringer Ingelheim (10 listings). [read post]
29 Mar 2024, 5:21 am
Case BackgroundEmpagliflozin (branded as Jardiance) is marketed in the EU by Eli Lilly and Boehringer Ingelheim for the treatment of type II diabetes (EU/1/14/930). [read post]
5 Mar 2024, 11:47 am
D.N.J. (18 July 2023) Xarelto Stelara Novo Nordisk D.N.J. (29 Sept. 2023) Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill Boehringer Ingelheim D. [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
13 Nov 2023, 4:10 pm
Boehringer Ingelheim Pharmaceuticals, Inc., Williams asks the court to grant review and reverse the 11th Circuit’s ruling. [read post]
4 Oct 2023, 10:00 pm
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
26 Jul 2023, 1:53 am
In an invalidity lawsuit filed by the Brazilian affiliate of Sun Pharma against Boehringer Ingelheim, Federal Judge Carvalho, sitting at the 9th Federal District Court in Rio de Janeiro, has granted a preliminary injunction ordering the Brazilian Patent and Trademark Office (BRPTO) to annotate that a second medical use patent (covering Ofev) doesn’t prevent the manufacturing and/or selling of generic or brand-generic nintedanib-based drugs for other uses. [read post]
26 Oct 2021, 12:41 am
On 8 October 2021, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in an action brought by Royalty Pharma Collection Trust (“Royalty Pharma”) for approximately €23 million in royalty payments from Boehringer Ingelheim GmbH (“Boehringer”) (Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH [2021] EWHC 2692 (Pat)). [read post]
26 Oct 2021, 12:41 am
On 8 October 2021, His Honour Judge Hacon (sitting as a Judge of the High Court) handed down his decision in an action brought by Royalty Pharma Collection Trust (“Royalty Pharma”) for approximately €23 million in royalty payments from Boehringer Ingelheim GmbH (“Boehringer”) (Royalty Pharma Collection Trust v Boehringer Ingelheim GmbH [2021] EWHC 2692 (Pat)). [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle
22 Oct 2020, 8:23 am
It cites and follows two notable precedents in which similar conclusions were reached: a 2012 decision in proceedings between Boehringer Ingelheim and Teva [here] and a 2016 decision between Novartis and Teva [here]. [read post]
20 May 2020, 8:27 am
The first lawsuit against Zantac was filed in 2019 in California, where the plaintiffs claimed that both Sanofi and Boehringer Ingelheim (pharmaceutical companies) knew they were pushing products that had carcinogens in them. [read post]
10 May 2020, 8:27 am
The first lawsuit against Zantac was filed in 2019 in California, where the plaintiffs claimed that both Sanofi and Boehringer Ingelheim (pharmaceutical companies) knew they were pushing products that had carcinogens in them. [read post]
5 Apr 2020, 9:57 pm
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
11 Dec 2019, 8:40 am
Zantac Class Action Lawsuits Recently, two class-action lawsuits were filed against Zantac manufacturer Sanofi-Aventis LLC and Boehringer Ingelheim Pharmaceuticals, who previously held rights to Zantac, with plaintiffs claiming that the companies knowingly put patient health at risk. [read post]
